Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4. (Q47956436)
Jump to navigation
Jump to search
scientific article published on 14 August 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4. |
scientific article published on 14 August 2017 |
Statements
1 reference
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4. (English)
1 reference
1 reference
1 reference
1 reference
1 reference
Levi A Garraway
1 reference
Xiangpeng Dai
1 reference
Wenjian Gan
1 reference
Xiaoning Li
1 reference
Shangqian Wang
1 reference
Wei Zhang
1 reference
Ling Huang
1 reference
Shengwu Liu
1 reference
Jianping Guo
1 reference
Jinfang Zhang
1 reference
Ting Chen
1 reference
Kouhei Shimizu
1 reference
Mirjam Blattner
1 reference
Divya Vasudevan
1 reference
Dennis L Buckley
1 reference
Jun Qi
1 reference
Lorenz Buser
1 reference
Pengda Liu
1 reference
Hiroyuki Inuzuka
1 reference
Andrew H Beck
1 reference
Liewei Wang
1 reference
Peter J Wild
1 reference
Kwok-Kin Wong
1 reference
Senthil K Muthuswamy
1 reference
Jiaoti Huang
1 reference
Yu Chen
1 reference
James E Bradner
1 reference
Wenyi Wei
1 reference
14 August 2017
1 reference
1 reference
23
1 reference
9
1 reference
1063-1071
1 reference
Identifiers
1 reference
1 reference
1 reference